Dallah Healthcare Co (SAU:4004) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4004 Dallah Healthcare Co SAU:4004
93 GF Score
Price ﷼107.40
GF Value ﷼206.43
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Dallah Healthcare Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Dallah Healthcare Co Valuation Rank Related Terms

SAU:4004
93GF Score
Dallah Healthcare Co SAU:4004
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?

Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued. The current stock price of ﷼107.40 is trading 48% below its estimated GF Value™ of ﷼206.43. GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4004:

  • Valuation Rank:
  • GF Value™: ﷼206.43 vs. price of ﷼107.40 (48% below fair value)
  • GF Score™: 93/100 with 8 warning signs

No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dallah Healthcare Co Business Description

Address 1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
93GF Score

Get the complete analysis for SAU:4004

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼107.40
Price
﷼206.43
GF Value